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Human T-cell leukemia viruses type 1 and 2 (HTLV-1 and HTLV-
2) share a common genetic organization, expression strategy
and ability to infect and immortalize T-cells in vitro; however,
HTLV-1 and HTLV-2 are strikingly different in terms of clinical
impact. HTLV-1 is recognized as the aetiological agent of adult
T-cell leukemia/lymphoma (ATLL), and HTLV-associated mye-
olopathy/tropical spastic paraparesis (HAM/TSP), in contrast,
HTLV-2 does not cause hematologic disorders and is only sporad-
ically associated with cases of subacute myelopathy. HTLV-1 and
HTLV-2 also exhibit distinct cellular tropisms in vivo: HTLV-1 is
mainly found in CD4+ T lymphocytes, whereas CD8+ T-cells are
the preferred target for HTLV-2.
The articles contributed in this Research Topic are covering all
the different aspects that characterize HTLV-1 and HTLV-2, by
highlighting differences in their biology that might provide clues
to their distinct pathogenic properties.
Emphasis was placed on the comparison of mRNA expression
(Cavallari et al., 2013), the genetic organization and expression
patterns (Ciminale et al., 2014), the structural and functional
properties of HTLV-1 and HTLV-2 Tax proteins (Forlani et al.,
2013; Ren andCheng, 2013; Romanelli et al., 2013; Shirinian et al.,
2013), the role of accessory proteins and antisense proteins in
viral pathogenesis (Anupam et al., 2013; Barbeau et al., 2013),
and the mechanisms of HIV-1/HTLV-1 and HIV-1/HTLV-2
co-infections (Pilotti et al., 2013).
The fine tuning of expression of HTLV-1 and HTLV-2
(Cavallari et al., 2013) was focused on the X region that codes
for the regulatory and accessory proteins in partially overlapping
ORFs. Expression of such compact genomes is accomplished by a
combination of ribosomal frameshifting, alternative splicing and
polycistronic translation as well as production of negative-strand
transcripts that code for the HBZ and APH-2 proteins. Recent
studies of the temporal sequence of HTLV-1 gene expression in
PBMCs isolated from infected patients revealed a “two-phase”
kinetics in which tax/rex mRNA expression precedes that of other
viral transcripts. A similar analysis of HTLV-2 mRNA expression
indicated a comparable expression pattern, although HTLV-2 is
characterized by a more abundant expression of gene products
that may favor viral latency (i.e., p28 and tRex).
Given the relevance of Tax in the initial steps of T-cell trans-
formation, their key role as the main viral oncoproteins was
discussed in four different articles, each one focusing on a spe-
cific aspect of Tax function. Romanelli et al. (2013), highlighted
distinctive properties of Tax proteins with emphasis on the activa-
tion of the NF-κB pathways and interactions with host factors that
participate in signal trasduction. Tax-1 and Tax-2, though shar-
ing many common properties, significantly differ for the presence
of a PDZ motif, which is missing in Tax-2. This motif mediates
the interaction of Tax with host factors regulating the cell cycle;
in addition Tax-2 is unable to activate the non-canonical NF-κB
which is attributed only to Tax-1. Shirinian et al. (2013), specif-
ically addressed the subcellular localization and trafficking of
Tax-1 and Tax-2, and their effects on cellular regulatory proteins.
A special attention was given to Tax-1/Tax-2 post-translational
modifications, as well to NF-κB activation and protein-protein
interactions involved in oncogenecity both in vivo and in vitro.
Ren and Cheng (2013), discussed their recent observations and
views on the differential transforming activity of Tax-1 and Tax-2
in human T cells. Both proteins are unable to immortalize CD8
cells but Tax-2 is more efficient than Tax-1 in immortalizing
CD4 cells. Forlani et al. (2013), discussed the pivotal role of
the class II transactivator (CIITA) in triggering the adaptive
immune response against pathogens. CIITA acts as an endoge-
nous restriction factor against HTLV-1 and HTLV-2 by targeting
their viral transactivators Tax-1 and Tax-2. The authors reviewed
their findings on CIITA-mediated inhibition of viral replication
and discussed similarities and differences in the molecular mech-
anisms by which CIITA specifically counteracts the function of
Tax proteins.
The function of the Rex protein was presented by Ciminale
et al. (2014). Although Rex-1 and Rex-2 share a similar domain
structure, the truncated forms of Rex-2 are capable of inhibiting
Rex function, while their HTLV-1 homolog p21 Rex might lack
this activity.
The role in viral replication and viral pathogenesis of acces-
sory proteins HTLV-1 p30 and HTLV-2 p28 were highlighted
by Anupam et al. (2013). Both p30 and p28 regulate viral gene
expression at the post-transcriptional level whereas p30 can also
function at the transcriptional level. Since p30 and p28 have dis-
tinct interactome profiles even though they both interact with
similar proteins, they must have divergent functions during the
lifecycle of the viruses.
The functions of other accessory proteins have been presented
by Ciminale et al. (2014). HTLV-1 p13 and p8 are not expressed
by HTLV-2 which codes for p11, whose function is still unclear
and does not seem to have a homolog in HTLV-1.
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The possible role played by antisense proteins HTLV-1 HBZ
and HTLV-2 APH-2 in the establishment of pathologies induced
by viral infection has been carefully considered by Barbeau et al.
(2013). Unlike APH-2, HBZ possesses specific domains which
mediate its capacity to enhance its own expression, deregulate
several pathways and induce T cell proliferation, providing sub-
stantial evidence toward its implication in viral persistence and
ATLL cell survival.
Finally the problem of HIV/HTLV co-infection has been dis-
cussed by Pilotti et al. (2013). During co-infection with HIV-1,
HTLV-2 modulates the cellular microenvironment favoring its
own propagation and inhibiting HIV-1 progression. Possible
differences between HTLV-1 and HTLV-2 on innate immune
mechanisms induction and a particularly impact on NK cells are
becoming evident.
In conclusion, in this Research Topic, HTLV-1 and HTLV-2
have been thoroughly compared and major differences outlined
and discussed. Of particular interest is that HTLV-2 infection,
contrary to HTLV-1, is characterized by an oligoclonal distri-
bution in asymptomatic hosts; this indicates that the etiology
of malignant transformation by HTLV-1 cannot be uniquely
attributed to this phenomenon and further investigation is
needed to understand why HTLV-2 is defective in promoting
leukemogenesis.
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